XML 141 R105.htm IDEA: XBRL DOCUMENT v3.21.2
INFORMATION ABOUT COMPONENTS OF EQUITY - Rizobacter Argentina and Insuagro (Details) - USD ($)
12 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2018
Financial position        
Current assets $ 211,489,658 $ 164,693,055 $ 98,208,964  
Non-current assets 183,100,299 132,868,314 144,258,333  
Total assets 394,589,957 297,561,369 242,467,297  
Current liabilities 168,037,855 130,610,709 116,458,133  
Non-current liabilities 136,261,798 106,201,178 63,914,298  
Total liabilities 304,299,653 236,811,887 180,372,431  
Equity attributable to controlling interest 67,743,242 46,179,395 47,301,863  
Equity attributable to non-controlling interest 22,547,062 14,570,087 14,793,003  
Total equity 90,290,304 60,749,482 62,094,866 $ 33,133,656
Total liabilities and equity 394,589,957 297,561,369 242,467,297  
Summary statements of comprehensive income or loss        
Revenues 209,526,177 173,092,172 160,605,296  
Initial recognition and changes in the fair value of biological assets 2,826,255 716,741 279,945  
Cost of sales (118,641,803) (93,575,588) (86,964,881)  
Gross margin 90,884,374 79,516,584 73,640,415  
Research and development expenses (5,617,655) (4,195,270) (3,689,391)  
Selling, general and administrative expenses (47,601,901) (38,345,028) (39,243,800)  
Share of profit or loss of joint ventures and associates 997,429 2,477,193 1,012,486  
Other income (279,359) (307,499) 365,900  
Operating profit 38,382,888 39,145,980 32,085,610  
Financial results (27,852,340) (32,702,642) (41,458,217)  
Profit (loss) before income tax 10,530,548 6,443,338 (9,372,607)  
Income tax expense (14,351,170) (2,206,710) (6,986,284)  
Result for the year (3,820,622) 4,236,628 (16,358,891)  
Exchange differences on translation of foreign operations 10,076,208 (10,108,444) 5,240,151  
Revaluation of property, plant and equipment, net of tax [1] (2,268,839) 3,399,683 (1,441,132)  
Total comprehensive profit (loss) $ 6,230,696 $ (5,445,488) $ (12,454,526)  
Rizobacter Argentina        
Summarized financial information        
Proportion of ownership interests held by non-controlling interests 20.00% 20.00% 20.00%  
Financial position        
Current assets $ 175,827,504 $ 148,256,827 $ 115,546,951  
Non-current assets 59,868,513 49,843,457 47,418,450  
Total assets 235,696,017 198,100,284 162,965,401  
Current liabilities 119,966,445 129,838,941 100,590,919  
Non-current liabilities 57,480,984 32,935,399 34,788,705  
Total liabilities 177,447,429 162,774,340 135,379,624  
Equity attributable to controlling interest 58,246,057 35,324,227 27,584,666  
Equity attributable to non-controlling interest 2,531 1,717 1,111  
Total equity 58,248,588 35,325,944 27,585,777  
Total liabilities and equity 235,696,017 198,100,284 162,965,401  
Summary statements of comprehensive income or loss        
Revenues 189,749,478 162,404,866 156,741,933  
Initial recognition and changes in the fair value of biological assets 1,552,746 716,741    
Cost of sales (106,636,141) (86,533,561) (85,287,771)  
Gross margin 84,666,083 76,588,046 71,454,162  
Research and development expenses (3,208,904) (2,689,468) (2,367,727)  
Selling, general and administrative expenses (37,500,952) (36,103,289) (31,316,843)  
Share of profit or loss of joint ventures and associates 481,442 1,960,549 1,071,297  
Other income 507,246 (380,871) 286,626  
Operating profit 44,944,915 39,374,967 39,127,515  
Financial results (11,032,748) (30,014,131) (24,650,359)  
Profit (loss) before income tax 33,912,167 9,360,836 14,477,156  
Income tax expense (14,141,515) (3,830,106) (7,729,300)  
Result for the year 19,770,652 5,530,730 6,747,856  
Exchange differences on translation of foreign operations 1,704,590 1,281,974 17,197  
Revaluation of property, plant and equipment, net of tax (2,682,457) 3,921,091 (1,347,124)  
Total comprehensive profit (loss) $ 18,792,785 $ 10,733,795 $ 5,417,929  
Insumos Agroquimicos S.A.        
Summarized financial information        
Proportion of ownership interests held by non-controlling interests 49.90%      
Summary statements of comprehensive income or loss        
Revenues $ 7,600,041      
Cost of sales (5,886,326)      
Gross margin 1,713,715      
Selling, general and administrative expenses (1,065,147)      
Other income 18,305      
Operating profit 666,873      
Financial results (961,635)      
Profit (loss) before income tax (294,762)      
Income tax expense 127,876      
Result for the year (166,886)      
Exchange differences on translation of foreign operations 180,519      
Total comprehensive profit (loss) $ 13,633      
[1] The tax effect of the revaluation of property, plant and equipment was ($1,389,643), ($1,133,230) and $480,378 for the years ended June 30, 2021, 2020 and 2019, respectively.